Industry: Service & Software
Published Date: 2025-05-30
Pages: 97 Pages
Report ld: 4748151
Request Sample
Customized Report
Recombinant Protein Production Service Market Size(US$)

CAGR 2025-2031
5.1%
Market Size,2031
USD 2,452
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Recombinant Protein Production Service was valued at US$ 1729 million in the year 2024 and is projected to reach a revised size of US$ 2452 million by 2031, growing at a CAGR of 5.1% during the forecast period.
A recombinant protein production service is a specialized biotechnology service that focuses on the large-scale generation of proteins using genetically modified host systems, enabling the production of proteins that may be difficult to obtain from natural sources or require specific modifications. The process involves cloning a target gene into an expression vector (such as plasmids), introducing it into host cells (e.g., bacteria like E. coli, yeast, insect, or mammalian cells), and optimizing conditions to drive efficient protein synthesis. Services typically encompass upstream processes (cell line development, transfection, and fermentation) and downstream processes (purification, filtration, and formulation), with options for customizing parameters like expression scale (milligrams to kilograms), post-translational modifications (glycosylation, phosphorylation), and purity requirements (e.g., >95% purity for research vs. GMP-grade for clinical use). These services are critical for applications ranging from drug discovery (e.g., monoclonal antibodies, enzyme therapies) and vaccine development to industrial biocatalysis and academic research, as they provide consistent, high-quality proteins tailored to specific functional, structural, or regulatory needs. Providers often leverage advanced technologies like codon optimization, perfusion culture systems, and affinity chromatography to enhance yield, reproducibility, and cost-effectiveness, ensuring reliable results for clients in biopharmaceuticals, academia, and industrial biotechnology.
North American market for Recombinant Protein Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Protein Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant Protein Production Service in Biomedicine is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant Protein Production Service include Charles River, Biomatik, R&D Systems, Applied Biological Materials Inc. (abm), VectorBuilder, BiologicsCorp, Proteos, RayBiotech, Leinco Technologies, Kinexus Bioinformatics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Production Service.
The Recombinant Protein Production Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Protein Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Protein Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Production Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mammalian Cell Based
1.2.3 Bacteria Based
1.2.4 Insect Cell Based
1.2.5 Others
1.3 Market by Application
1.3.1 Global Recombinant Protein Production Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedicine
1.3.3 Industrial Biotechnology
1.3.4 Therapeutics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Protein Production Service Market Perspective (2020-2031)
2.2 Global Recombinant Protein Production Service Growth Trends by Region
2.2.1 Global Recombinant Protein Production Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Protein Production Service Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Protein Production Service Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Protein Production Service Market Dynamics
2.3.1 Recombinant Protein Production Service Industry Trends
2.3.2 Recombinant Protein Production Service Market Drivers
2.3.3 Recombinant Protein Production Service Market Challenges
2.3.4 Recombinant Protein Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Production Service Players by Revenue
3.1.1 Global Top Recombinant Protein Production Service Players by Revenue (2020-2025)
3.1.2 Global Recombinant Protein Production Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Protein Production Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Protein Production Service Revenue
3.4 Global Recombinant Protein Production Service Market Concentration Ratio
3.4.1 Global Recombinant Protein Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Production Service Revenue in 2024
3.5 Global Key Players of Recombinant Protein Production Service Head office and Area Served
3.6 Global Key Players of Recombinant Protein Production Service, Product and Application
3.7 Global Key Players of Recombinant Protein Production Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Protein Production Service Breakdown Data by Type
4.1 Global Recombinant Protein Production Service Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Protein Production Service Forecasted Market Size by Type (2026-2031)
5 Recombinant Protein Production Service Breakdown Data by Application
5.1 Global Recombinant Protein Production Service Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Protein Production Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Protein Production Service Market Size (2020-2031)
6.2 North America Recombinant Protein Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Protein Production Service Market Size by Country (2020-2025)
6.4 North America Recombinant Protein Production Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Protein Production Service Market Size (2020-2031)
7.2 Europe Recombinant Protein Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Protein Production Service Market Size by Country (2020-2025)
7.4 Europe Recombinant Protein Production Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Production Service Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Protein Production Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Protein Production Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Protein Production Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Protein Production Service Market Size (2020-2031)
9.2 Latin America Recombinant Protein Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Protein Production Service Market Size by Country (2020-2025)
9.4 Latin America Recombinant Protein Production Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Production Service Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Protein Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Protein Production Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Protein Production Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Recombinant Protein Production Service Introduction
11.1.4 Charles River Revenue in Recombinant Protein Production Service Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Biomatik
11.2.1 Biomatik Company Details
11.2.2 Biomatik Business Overview
11.2.3 Biomatik Recombinant Protein Production Service Introduction
11.2.4 Biomatik Revenue in Recombinant Protein Production Service Business (2020-2025)
11.2.5 Biomatik Recent Development
11.3 R&D Systems
11.3.1 R&D Systems Company Details
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems Recombinant Protein Production Service Introduction
11.3.4 R&D Systems Revenue in Recombinant Protein Production Service Business (2020-2025)
11.3.5 R&D Systems Recent Development
11.4 Applied Biological Materials Inc. (abm)
11.4.1 Applied Biological Materials Inc. (abm) Company Details
11.4.2 Applied Biological Materials Inc. (abm) Business Overview
11.4.3 Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Introduction
11.4.4 Applied Biological Materials Inc. (abm) Revenue in Recombinant Protein Production Service Business (2020-2025)
11.4.5 Applied Biological Materials Inc. (abm) Recent Development
11.5 VectorBuilder
11.5.1 VectorBuilder Company Details
11.5.2 VectorBuilder Business Overview
11.5.3 VectorBuilder Recombinant Protein Production Service Introduction
11.5.4 VectorBuilder Revenue in Recombinant Protein Production Service Business (2020-2025)
11.5.5 VectorBuilder Recent Development
11.6 BiologicsCorp
11.6.1 BiologicsCorp Company Details
11.6.2 BiologicsCorp Business Overview
11.6.3 BiologicsCorp Recombinant Protein Production Service Introduction
11.6.4 BiologicsCorp Revenue in Recombinant Protein Production Service Business (2020-2025)
11.6.5 BiologicsCorp Recent Development
11.7 Proteos
11.7.1 Proteos Company Details
11.7.2 Proteos Business Overview
11.7.3 Proteos Recombinant Protein Production Service Introduction
11.7.4 Proteos Revenue in Recombinant Protein Production Service Business (2020-2025)
11.7.5 Proteos Recent Development
11.8 RayBiotech
11.8.1 RayBiotech Company Details
11.8.2 RayBiotech Business Overview
11.8.3 RayBiotech Recombinant Protein Production Service Introduction
11.8.4 RayBiotech Revenue in Recombinant Protein Production Service Business (2020-2025)
11.8.5 RayBiotech Recent Development
11.9 Leinco Technologies
11.9.1 Leinco Technologies Company Details
11.9.2 Leinco Technologies Business Overview
11.9.3 Leinco Technologies Recombinant Protein Production Service Introduction
11.9.4 Leinco Technologies Revenue in Recombinant Protein Production Service Business (2020-2025)
11.9.5 Leinco Technologies Recent Development
11.10 Kinexus Bioinformatics
11.10.1 Kinexus Bioinformatics Company Details
11.10.2 Kinexus Bioinformatics Business Overview
11.10.3 Kinexus Bioinformatics Recombinant Protein Production Service Introduction
11.10.4 Kinexus Bioinformatics Revenue in Recombinant Protein Production Service Business (2020-2025)
11.10.5 Kinexus Bioinformatics Recent Development
11.11 InVivo BioTech Services GmbH
11.11.1 InVivo BioTech Services GmbH Company Details
11.11.2 InVivo BioTech Services GmbH Business Overview
11.11.3 InVivo BioTech Services GmbH Recombinant Protein Production Service Introduction
11.11.4 InVivo BioTech Services GmbH Revenue in Recombinant Protein Production Service Business (2020-2025)
11.11.5 InVivo BioTech Services GmbH Recent Development
11.12 Expression Systems
11.12.1 Expression Systems Company Details
11.12.2 Expression Systems Business Overview
11.12.3 Expression Systems Recombinant Protein Production Service Introduction
11.12.4 Expression Systems Revenue in Recombinant Protein Production Service Business (2020-2025)
11.12.5 Expression Systems Recent Development
11.13 Creative Biolabs
11.13.1 Creative Biolabs Company Details
11.13.2 Creative Biolabs Business Overview
11.13.3 Creative Biolabs Recombinant Protein Production Service Introduction
11.13.4 Creative Biolabs Revenue in Recombinant Protein Production Service Business (2020-2025)
11.13.5 Creative Biolabs Recent Development
11.14 G &P Biosciences
11.14.1 G &P Biosciences Company Details
11.14.2 G &P Biosciences Business Overview
11.14.3 G &P Biosciences Recombinant Protein Production Service Introduction
11.14.4 G &P Biosciences Revenue in Recombinant Protein Production Service Business (2020-2025)
11.14.5 G &P Biosciences Recent Development
11.15 Eurofins Discovery
11.15.1 Eurofins Discovery Company Details
11.15.2 Eurofins Discovery Business Overview
11.15.3 Eurofins Discovery Recombinant Protein Production Service Introduction
11.15.4 Eurofins Discovery Revenue in Recombinant Protein Production Service Business (2020-2025)
11.15.5 Eurofins Discovery Recent Development
11.16 Levprot Bioscience
11.16.1 Levprot Bioscience Company Details
11.16.2 Levprot Bioscience Business Overview
11.16.3 Levprot Bioscience Recombinant Protein Production Service Introduction
11.16.4 Levprot Bioscience Revenue in Recombinant Protein Production Service Business (2020-2025)
11.16.5 Levprot Bioscience Recent Development
11.17 eEnzyme
11.17.1 eEnzyme Company Details
11.17.2 eEnzyme Business Overview
11.17.3 eEnzyme Recombinant Protein Production Service Introduction
11.17.4 eEnzyme Revenue in Recombinant Protein Production Service Business (2020-2025)
11.17.5 eEnzyme Recent Development
11.18 NorthX Biologics
11.18.1 NorthX Biologics Company Details
11.18.2 NorthX Biologics Business Overview
11.18.3 NorthX Biologics Recombinant Protein Production Service Introduction
11.18.4 NorthX Biologics Revenue in Recombinant Protein Production Service Business (2020-2025)
11.18.5 NorthX Biologics Recent Development
11.19 Xpress Biologics
11.19.1 Xpress Biologics Company Details
11.19.2 Xpress Biologics Business Overview
11.19.3 Xpress Biologics Recombinant Protein Production Service Introduction
11.19.4 Xpress Biologics Revenue in Recombinant Protein Production Service Business (2020-2025)
11.19.5 Xpress Biologics Recent Development
11.20 Jubilant Biosys
11.20.1 Jubilant Biosys Company Details
11.20.2 Jubilant Biosys Business Overview
11.20.3 Jubilant Biosys Recombinant Protein Production Service Introduction
11.20.4 Jubilant Biosys Revenue in Recombinant Protein Production Service Business (2020-2025)
11.20.5 Jubilant Biosys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Recombinant Protein Production Service market is projected to grow from US$ 1819 million in 2025 to US$ 2564 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-15
Pages: 170
USD 4900.00
(Single User License)
The global Recombinant Protein Production Service market size was US$ 1819 million in 2025 and is forecast to reach a readjusted size of US$ 2564 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-03-15
Pages: 113
USD 4250.00
(Single User License)
The global market for Recombinant Protein Production Service was estimated to be worth US$ 1819 million in 2025 and is projected to reach US$ 2564 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 143
USD 3950.00
(Single User License)
The global Recombinant Protein Production Service market was valued at US$ 1819 million in 2025 and is anticipated to reach US$ 2564 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 145
USD 2900.00
(Single User License)
The global market for Recombinant Protein Production Service was estimated to be worth US$ 1729 million in 2024 and is forecast to a readjusted size of US$ 2452 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 133
USD 3950.00
(Single User License)
The global Recombinant Protein Production Service market size was US$ 1729 million in 2024 and is forecast to a readjusted size of US$ 2452 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 110
USD 4250.00
(Single User License)
The global Recombinant Protein Production Service market is projected to grow from US$ 1819 million in 2025 to US$ 2452 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.
Published Date: 2025-05-30
Pages: 155
USD 4900.00
(Single User License)
The global Recombinant Protein Production Service market is projected to grow from US$ 1819 million in 2025 to US$ 2564 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-15
Pages: 170
The global Recombinant Protein Production Service market size was US$ 1819 million in 2025 and is forecast to reach a readjusted size of US$ 2564 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-03-15
Pages: 113
The global market for Recombinant Protein Production Service was estimated to be worth US$ 1819 million in 2025 and is projected to reach US$ 2564 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-03-15
Pages: 143
The global Recombinant Protein Production Service market was valued at US$ 1819 million in 2025 and is anticipated to reach US$ 2564 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-03-15
Pages: 145
The global market for Recombinant Protein Production Service was estimated to be worth US$ 1729 million in 2024 and is forecast to a readjusted size of US$ 2452 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 133
The global Recombinant Protein Production Service market size was US$ 1729 million in 2024 and is forecast to a readjusted size of US$ 2452 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 110
The global Recombinant Protein Production Service market is projected to grow from US$ 1819 million in 2025 to US$ 2452 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.
Published: 2025-05-30
Pages: 155
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now